Breast oncology Clinical Trials in Middletown, NJ
As of June 2026, 36 paid clinical trials are recruiting for Breast oncology in Middletown, New Jersey. Breast oncology research tests new hormone therapies, HER2-targeted agents, PARP inhibitors, antibody-drug conjugates, and immunotherapy combinations across early-stage and metastatic disease. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
36 clinical trials for Breast oncology
·Clear filters·↓ Download CSVA Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer
HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term Remission
A Study of a Decision Tool for People Considering Breast Reconstruction Surgery
Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol
Factors Associated With Breast Cancer Risks and Outcomes
A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement
A Study of Surgery and Radiotherapy in People With Breast Cancer
A Study of Revaree Plus in People With Breast Cancer
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
A Study of Language Interpretation Solutions for People With Breast Cancer
A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer
A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer
A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors
A Study of Pembrolizumab and Cryoablation in People With Breast Cancer
A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer
A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
A Study of Blood Pressure Control During Cancer Treatment
Study of Aerobic Training for People Receiving Chemotherapy for Breast Cancer
Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer
A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer
A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control
Lymphedema Surveillance Study
Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations
About research studies in Middletown
Middletown has approximately 312 recruiting research studies across a wide range of therapeutic areas. New Jersey hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Middletown
Researchers run research studies in Middletown, NJ at 22 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Memorial Sloan Kettering Monmouth (Limited Protocol Activities) | Breast Cancer, Multiple Myeloma, Metastatic Breast Cancer | 115 |
| Memorial Sloan Kettering Monmouth | Acute Myeloid Leukemia, Breast Cancer, Stage IV Lung Cancer AJCC v8 | 79 |
| Memorial Sloan Kettering Monmouth (All Protocol Activities) | Breast Cancer, Non-Small Cell Lung Cancer, Endometrial Cancer | 59 |
| Memorial Sloan Kettering Monmouth (Consent Only) | Breast Cancer, Adolescents and Young Adults With Cancer, Adult Cancer Patients | 25 |
| MSK Monmouth | Multiple Myeloma, Advanced Colorectal Cancer (Part 1), Advanced Renal Cell Carcinoma | 8 |
| Memorial Sloan Kettering at Monmouth (Limited Protocol Activities) | Prostate Cancer, Breast Cancer, Breast Cancer Stage IV | 5 |
| MSK Monmouth. | Advanced Breast Cancer, Advanced Gastric Cancer, Advanced or Metastatic Solid Tumors | 2 |
| Memorial Sloan Kettering Monmouth (Consent and Follow-up) | Acute Myeloid Leukemia, Breast Cancer | 2 |
| Memorial Sloan Kettering Monmouth (Consent and Followup) | Bone Neoplasm, Bone Sarcoma, Chondrosarcoma | 2 |
| Memorial Sloan Kettering Monmouth - Limited Protocol Activities | Clinical Stage: Stage II (T3-4, N-), Intrahepatic Cholangiocarcinoma, Rectal Adenocarcinoma | 2 |
| Takeda | Narcolepsy Type 1 (NT1), Narcolepsy With Cataplexy, Narcolepsy Type 2 | 2 |
| Alkermes Investigational Site | Idiopathic Hypersomnia, Narcolepsy Type 1, Narcolepsy Type 2 | 1 |
| Alkermes Investigator Site | Idiopathic Hypersomnia | 1 |
| Clinical Study Site | Non-Small Cell Lung Cancer | 1 |
| Memoral Sloan Kettering Monmouth | Lymphoplasmacytic Lymphoma, Waldenstrom Macroglobulinemia | 1 |
| Memoral Sloan Kettering Monmouth (Consent only) | Tongue Cancer | 1 |
| Memorial Sloan Kettering - Monmouth | Non-small Cell Lung Cancer | 1 |
| Memorial Sloan Kettering Cancer Center | Adenocarcinoma, Pancreatic Ductal | 1 |
| Memorial Sloan Kettering Cancer Center - Monmouth | Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations | 1 |
| Memorial Sloan Kettering Monmouth (Consent and Follow up) | Renal Cancer | 1 |
| Patient First MD | Alzheimer Disease | 1 |
| Specialty Surgery Center of Middletown | Lumbar Spinal Stenosis | 1 |
Active & Upcoming Studies in Middletown (2026)
Recruiting trials in Middletown grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (252 active studies)
- A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate · Phase 1 · Memorial Sloan Kettering Cancer Center
- A Study of MSK-TCR5 in People With Solid Tumor Cancers · Phase 1 · Memorial Sloan Kettering Cancer Center
Neurology & pain (3 active studies)
- A Study Testing Topical Pain-Relieving Herbal Plasters in People Who Are Using Opioids for Their Pain · Phase 1 · Memorial Sloan Kettering Cancer Center
- A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1) · Phase 3 · Bristol-Myers Squibb
HIV / STI (1 active study)
- A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma · Phase 2 · Memorial Sloan Kettering Cancer Center
Mental health & behavior (1 active study)
- A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home · Memorial Sloan Kettering Cancer Center
Diabetes & metabolic (1 active study)
- A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer · Phase 1 · Memorial Sloan Kettering Cancer Center
Pediatric (1 active study)
- A Study of 177Lu-PSMA-617 in People With Gliomas · Phase 1 · Memorial Sloan Kettering Cancer Center
Common conditions studied in Middletown
- Breast Cancer (28 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Multiple Myeloma (13 active studies). Recruiting Multiple Myeloma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Acute Myeloid Leukemia (11 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Metastatic Breast Cancer (10 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Non-Small Cell Lung Cancer (10 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
- Prostate Cancer (9 active studies). Prostate cancer studies test next-generation hormone therapies, PARP inhibitors, and radioligand treatments for both localized and advanced disease.
Leading research sponsors in Middletown
- Memorial Sloan Kettering Cancer Center
- National Cancer Institute (NCI)
- NRG Oncology
- Pfizer
- Alliance for Clinical Trials in Oncology
Local regulations and guidelines
Clinical trials in New Jersey are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. New Jersey research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Middletown. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Middletown
Hipa.ai aggregates every recruiting study in Middletown from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Middletown?
There are approximately 312 recruiting clinical trials in Middletown, New Jersey listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Middletown pay participants?
Most recruiting trials in Middletown compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Middletown?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Middletown?
The most common conditions under active study in Middletown include Breast Cancer (28), Multiple Myeloma (13), Acute Myeloid Leukemia (11), Metastatic Breast Cancer (10), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Middletown?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Middletown on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Middletown?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Middletown?
Recruiting research sites in Middletown include Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Memorial Sloan Kettering Monmouth, Memorial Sloan Kettering Monmouth (All Protocol Activities), among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Middletown right now?
The largest active categories in Middletown are Cancer & tumors (252), Neurology & pain (3), HIV / STI (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.